Communication on immunisation – building trust
With an emphasis on the concepts of trust and transparency, this guide has been developed to assist those involved in planning and implementing health communication activities to promote immunisation. It builds on existing research and good practice developed by international organisations, with real-life examples of media coverage and communication campaigns for specific vaccines.
Coinciding with European Immunization Week, ECDC has issued a report highlighting the importance of building trust for public health organisations in order for them to communicate effectively on immunisation.
The document aims at supporting Member States in planning and implementing communication initiatives on vaccination, by presenting an overview of the main issues that public health institutions need to consider in relation to building and maintaining trust.
In the European Union, successful vaccination programmes have led to a substantial drop in the incidence of many infectious diseases. However, recent outbreaks of vaccine-preventable diseases such as measles confirm the challenges faced by public health authorities in maintaining optimum vaccination coverage levels.
The media, particularly new and social media, provide abundant and conflicting messages about vaccines’ effects and safety causing certain groups to question the benefits of vaccination, while others seem to be more worried about the adverse effects of a vaccine than about the disease itself.
In this context, public health institutions need to find effective ways to make their voice heard- and advice followed by the public. Transparency and trust appear to be key factors, even before undertaking any communication activities.
By summarising results from recent research on the preferred and most trusted sources of health information for the public, the report provides useful insights into issues to consider when deciding how to reach specific audiences, taking into account the challenges and opportunities posed by social media for communication on immunisation.
Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA) - Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
22 Jan 2020 - The Middle East respiratory syndrome coronavirus (MERS-CoV) was first discovered in 2012 in a patient who died from severe respiratory disease. Since then, and as of 16 January 2020, 2 521 cases have been reported worldwide, including 919 deaths (crude case fatality 36%). Most cases have been reported from the Arabian Peninsula (and around 84% specifically from Saudi Arabia), and all cases elsewhere had a travel history to the Arabian Peninsula or were a contact of someone who had a travel history to the region.
Influenza communication guide: How to increase influenza vaccination uptake and promote preventive measures to limit its spread
21 Nov 2019 - The influenza vaccination communication guide provide advice, guidance and campaign materials to support national influenza vaccination campaigns with the purpose of increasing the influenza vaccination uptake in the EU Member States.
Options for national testing and surveillance for hepatitis E virus in the EU/EEA - Operational guidance
5 Sep 2019 - This operational guidance, developed by ECDC in collaboration with its hepatitis E virus (HEV) expert group, offers options on the implementation or adjustment of HEV surveillance at a national level.